Articles tagged with Analgesics
A large Israeli pregnancy registry study found no association between first-trimester nonsteroidal anti-inflammatory drug (NSAID) use and major congenital malformations. The study analyzed over 264,000 pregnancies and found no increased risk of birth defects, even at higher doses.
A new study shows that while dental opioid prescription fills in the US have dropped by 27% since 2021, the rate remains higher than in other developed countries and the US territory of Puerto Rico. The study suggests that some US dentists are still overprescribing opioids.
A Phase II trial found that exercise can improve cognitive function in patients receiving chemotherapy, while low-dose ibuprofen may also have some benefits. The study suggests that exercise is more effective in improving cognitive outcomes, but further research is needed to explore the effects of ibuprofen and combination therapy.
A new study by University College London found that gabapentinoids, prescribed for chronic pain, double the risk of hospitalization for drug poisoning when combined with benzodiazepines or opioids. The risk persists even after starting gabapentinoid treatment, suggesting they may not be an effective solution to reduce poisoning risks.
Researchers have developed a low-cost fake drug detector that uses an infrared sensor to track pill dissolution rates. The device can identify legitimate medications from counterfeit ones with high accuracy, making it a valuable tool in the fight against global health threats.
A study in Taiwan found a positive association between maternal prenatal acetaminophen use and increased risk of attention-deficit/hyperactivity disorder (ADHD) and autism spectrum disorders (ASDs) in offspring. However, associations were not observed in sibling-matched analyses, suggesting unaddressed sources of bias.
A study found a significant decrease in acetaminophen use during pregnancy and a surge in leucovorin prescriptions after the September 2025 White House briefing. Leucovorin prescriptions increased approximately 71% above expected levels, mainly for children with autism diagnoses.
A new Cochrane review found that sucrose can effectively reduce pain in newborn babies during painful procedures like venepuncture. The study examined 29 clinical trials involving over 2,700 babies and showed that a small amount of sucrose given before the procedure significantly reduces pain when combined with non-nutritive sucking.
The UT Health San Antonio School of Dentistry has secured a $9 million NIH grant to develop a targeted, non-opioid treatment for chronic pain associated with muscle and joint dysfunction. Researchers will map the biology of facial pain, identify specialized neurons, and analyze gene expression changes to design effective treatments.
Daily aspirin use offers no quick or reliable way to prevent bowel cancer in the general population, increasing risk of serious bleeding. However, it may have potential long-term benefits for people at high genetic risk of colorectal cancer.
The study found that opioids provide only small, time-limited pain relief for certain pain conditions, such as stomach pain and dental surgery. Regular use of opioids comes with a risk of harm, including dependence and overdose.
A modified fentanyl molecule with a new core structure reduces respiratory depression while maintaining its pain-relieving properties. This redesign preserves the essential anchor point for receptor activation, producing pain relief without significant side effects.
A new study found that MET signaling plays a critical protective role in acetaminophen-induced acute liver failure by reducing liver damage and accelerating regeneration. The findings suggest targeting MET signaling could become a game-changer for treating drug-induced ALF, potentially reducing the need for emergency liver transplants.
A recent study found that low-dose aspirin use was not associated with incident cancer incidence in older adults, contrary to previous findings. However, the study revealed a significant elevation in cancer mortality risk during the randomized clinical trial period, which did not persist after the trial ended.
Research suggests that blocking growth factor receptor signaling using cancer drugs may overcome two challenges: managing oral cancer pain and preventing opioid tolerance. This approach could control cancer while addressing pain through a non-opioid, biologically rational approach.
A new study used deep learning and large-scale computer simulations to identify structural differences in synthetic cannabinoid molecules that cause them to bind to human brain receptors differently from classical cannabinoids. Researchers found that these substances often trigger the beta arrestin pathway, leading to more severe psych...
Researchers found that abstinent smokers have altered brain activity linked to increased pain sensitivity and a need for more postoperative pain relief. The study suggests that nicotine withdrawal affects specific brain regions, leading to higher requirements for pain management in surgery.
Headache disorders affect nearly one in every three people, causing significant disability and health loss. Migraine and medication overuse drive most of the global burden, emphasizing the need for improved prevention, management, and access to care.
Research finds existing evidence on paracetamol use during pregnancy does not clearly link it to autism or ADHD in children; studies suggest shared genetic and environmental factors within families may explain the observed risk. Women can be advised to take paracetamol when needed for pain and fever during pregnancy.
A new study by Rutgers University found that over-the-counter pain medications are as effective as opioids in reducing pain after tooth extraction for both men and women. The study's results confirm the analgesic effect of non-opioid medications, which were superior to opioids in terms of sleep quality and daily activity interference.
A comprehensive systematic review and meta-analysis published in the Journal of the American Academy of Child & Adolescent Psychiatry found no association between prenatal acetaminophen exposure and the risk of neurodevelopmental disorders, including autism and ADHD. The study offers reassurance for pregnant women, public health agenci...
A pooled data analysis found tramadol to be ineffective in easing chronic pain, with a small and clinically insignificant effect. The use of tramadol was also associated with an increased risk of serious side effects, including heart disease and certain cancers.
Researchers discovered a new enzyme produced by Bacteroides fragilis that activates pain signaling. The enzyme is targeted with nanoparticles to develop treatments for gut pain in inflammatory bowel disease and irritable bowel syndrome. The studies aim to restore balance between good and bad bacteria to reduce symptoms.
Scientists at NYU Pain Research Center identified the EP2 receptor as the main cause of inflammatory pain but not inflammation. Blocking this receptor silenced pain responses without affecting inflammation, offering a new strategy for treating prostaglandin-mediated pain.
A new study suggests that low-dose aspirin can prevent cancer in older adults based on individual characteristics. The analysis found varying treatment effects among participants, highlighting the need for personalized approaches to cancer prevention.
Inflammasome activation plays a key role in acetaminophen-induced hepatotoxicity, triggering oxidative stress, mitochondrial dysfunction, and inflammation. Targeting inflammasome signaling offers promising therapeutic approaches, including NLRP3 inhibitors, caspase-1 inhibitors, and anti-inflammatory agents.
Researchers have identified two key brainstem regions involved in pain relief, with distinct patterns of activity depending on the location of pain. This discovery may pave the way for safer, more targeted treatments for chronic pain without relying on opioids.
Research from the University of South Australia finds that ibuprofen and paracetamol drive antibiotic resistance when used individually, but amplifying it when combined. The study also reveals that common bacteria like E. coli become highly resistant to antibiotics and multiple other medications.
A new Cochrane review has found no clear evidence of benefit for ketamine in treating chronic pain conditions. The review identified an increased risk of adverse effects such as delusions and vomiting. High-quality trials are needed to determine the role of ketamine in chronic pain care.
A parasitic worm has evolved to suppress neurons in the skin to evade detection, reducing its own survival. Researchers discovered that the worm produces molecules blocking TRPV1+ activity, essential for pain sensation and immune responses, allowing it to infect the skin undetected.
Researchers have discovered a way to distinguish identical medicines at the molecular level, allowing for the tracing of counterfeit or stolen medicine. The technology focuses on variants of chemical elements such as isotopes of carbon, hydrogen, and oxygen.
Researchers found that injecting botox directly into the TMJ alleviated TMD-related pain, hypersensitivity, and neural activity, while preserving movement abilities. The study suggests avoiding muscle tissue to overcome botox side effects and offers new hope for treating jaw disorders.
Researchers at Kyoto University have discovered a novel analgesic called ADRIANA, which targets the α2B-adrenoceptor and exerts its effect without causing cardiovascular instability. The compound has shown highly promising results in non-clinical studies and early clinical trials.
Researchers found that external cues alleviated pain for all participants but only half reported less pain with placebo treatment. Predictive cues were less impactful when patients received placebo treatment. The study suggests cue-based expectations have more consistent effects than treatment-based expectations.
Researchers discovered a new pathway to boost immunity against parasitic infections, suggesting that NSAIDs like ibuprofen could be repurposed as anti-parasitic treatments. Gasdermin C plays a crucial role in this process, targeting and penetrating Rab7-positive vesicles to reduce prostaglandin d2 levels.
A large medical record study found that receiving six or more gabapentin prescriptions for low back pain significantly increases the risk of developing dementia (29% higher) and mild cognitive impairment (85% higher). Risks are particularly high among 18-64 year olds, with no age group considered safe from increased risks.
A study of over 2,500 adults aged 50-80 found that nearly 1 in 6 take aspirin for cardiovascular protection without a history of heart disease. Despite revised guidelines reducing aspirin use for primary prevention after age 70, many patients are unaware of the increased risk of bleeding.
A new study found that Black emergency department patients are less likely to be treated with opioids, but when their preferences are not met, they are at a higher risk of misusing opioids three months later. Patients who were satisfied with their pain care had lower rates of opioid misuse.
Researchers identified a key brain region, the ventrolateral periaqueductal gray matter (vIPAG), that modulates pain and emotional responses in threatening situations. By inhibiting specific cells within this region, scientists discovered a potential pathway for better pain relief.
The UT Health San Antonio Multispecialty and Research Hospital is the first in Texas to approve use of suzetrigine, a new non-opioid medication for post-surgical pain. This medication targets the peripheral nervous system, avoiding opioid-related side effects.
A study published in The Journal of Pain found that nature exposure can help people with chronic lower back pain by providing a sense of escapism, social connection, and physical exercise. Researchers recommend incorporating accessible design features into natural spaces to improve inclusivity.
A new book by Professor Aldrin Gomes details the benefits and risks of ibuprofen, including its interaction with over 400 prescription drugs and impact on cardiovascular health. The comprehensive guide aims to educate readers about responsible painkiller use and natural alternatives.
SBI-810, a non-opioid treatment, activates a specific pain-relief pathway that avoids the euphoric high linked to addiction. The compound effectively relieved pain from surgical incisions and nerve injuries better than some existing painkillers.
Researchers at State University of Campinas found that physical exercise prevents the transition from acute to chronic muscle pain by activating an anti-inflammatory signaling pathway in immune cells. This can lead to the development of new treatments for muscle pain, potentially reducing opioid consumption.
Scientists at the University of Southern California have developed a wearable lactation pad that monitors breast milk for safe levels of acetaminophen. The device provides real-time information, enabling parents to make informed decisions about breastfeeding and medication use, and may also be adapted to detect other drugs and biomarkers.
A synthetic peptide derived from neurotoxin GsMTx4 has been found to alleviate mechanical hyperalgesia and neuropathic pain through the TRPV4 channel. The peptide's analgesic effects are comparable to those of morphine, but without any side effects.
A new study found that both employed people with obesity and employer representatives acknowledge the impact of obesity on future health problems and perceive lifestyle change alongside anti-obesity medications as the most effective approach for maintaining weight-loss reduction. Cost of medication coverage remains a significant barrie...
A team of scientists at the University of Florida has developed a new drug compound that selectively targets delta opioid receptors, providing pain relief without the dangerous side effects associated with opioids. The study's findings offer a promising approach to developing safer pain treatments, which could also be applied to treati...
Researchers discovered a mechanism that harnesses immune cells to produce opioids, potentially alleviating chronic pain. Estrogen and progesterone drive this process, which could lead to more effective treatments for women experiencing pain after menopause.
Researchers from Florida Atlantic University challenge the current aspirin guidelines based on a flawed trial, advocating for healthcare providers to make individual clinical judgments about prescribing aspirin. They stress that patients should consult their primary care provider to balance the benefits of clot prevention against bleed...
Patients prescribed medicinal cannabis in Australia showed long-term improvements in overall health-related quality of life, fatigue, and sleep disturbance. The study, which recruited over 2,300 participants, also found improvements in anxiety, depression, insomnia, and pain for those with corresponding conditions.
Scientists at ISTA create a new brain organoid model that incorporates microglia to study viral infections, such as Rubella, and test the effectiveness of ibuprofen. The results show that microglia play a crucial role in inflammatory reactions and that ibuprofen exerts its protective effects by inhibiting two inflammatory enzymes.
Scientists at the University of South Australia have developed a phospholipid complex to improve cannabidiol's effectiveness in treating epilepsy, multiple sclerosis, and other neurodegenerative diseases. The new formula increases cannabidiol's solubility by up to six times and improves its absorption in the gastrointestinal tract.
The ASCOLT trial found that aspirin does not statistically improve disease-free survival for all patients but demonstrates a consistent trend of improving overall and disease-free survival. Aspirin taken for up to 3 years is efficacious in patients with PIK3CA mutation, reducing recurrence by over 50%.
A new study suggests that statins can reduce chest muscle loss in smokers, while aspirin may contribute to increased muscle loss. The study examined data from 4,191 participants and found that statins protected pectoralis muscle area and density, whereas aspirin led to decreased muscle mass.
A new study found that viewing nature can help ease how people experience pain by reducing the brain activity linked to pain perception. The research suggests that the pain-relieving effect of nature is genuine and could provide an alternative way to relieve pain, potentially used in conjunction with medication.
A new study by Boston University School of Public Health refutes claims that Medicaid expansion increases misuse of prescription opioids and benzodiazepines. Despite initial concerns, the study found no association between Medicaid expansion and non-prescribed opioid use among people who inject drugs.
Researchers are conducting a clinical trial to find the optimal combination of pain management tools for patients undergoing mastectomy procedures. The study will enroll approximately 100 patients and examine various combinations of pectoralis nerve blocks, non-opioid analgesics, and administration methods.
A NIH-funded research team has engineered a medication that targets the body's cannabinoid receptor type 1 (CB1), which shows promise in treating acute and chronic pain. The new drug, VIP36, is more 'peripherally restricted' compared to previous drugs, reducing unwanted side effects.
Researchers found that aspirin prevents cancers from spreading by decreasing a clotting factor called thromboxane A2 and releasing T cells from suppression. This discovery could lead to the development of targeted treatments to prevent cancer metastasis, making aspirin potentially less expensive than antibody-based therapies.